Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001457612-22-000024
Filing Date
2022-03-17
Accepted
2022-03-17 16:04:21
Documents
1
Period of Report
2022-03-15

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_164754743709345.html 4  
1 FORM 4 wf-form4_164754743709345.xml 4 7327
  Complete submission text file 0001457612-22-000024.txt   8817
Mailing Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140
Business Address 100 ACORN PARK DRIVE CAMBRIDGE MA 02140 617-876-8191
GENOCEA BIOSCIENCES, INC. (Issuer) CIK: 0001457612 (see all company filings)

EIN.: 510596811 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O GENOCEA BIOSCIENCES, INC. 100 ACORN PARK DRIVE, 5TH FLOOR CAMBRIDGE MA 02140
Business Address
Aakalu Girish N (Reporting) CIK: 0001761614 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36289 | Film No.: 22748451